two
recent
detect
virus
human
metapneumoviru
hmpv
coronaviru
associ
acut
respiratori
tract
infect
particularli
young
children
studi
investig
frequenc
hmpv
infect
swedish
children
screen
nasopharyng
aspir
collect
novemb
may
children
attend
paediatr
depart
counti
hospit
sweden
submit
local
gener
practition
sampl
origin
submit
test
respiratori
syncyti
viru
rsv
examin
retrospect
hmpv
rtpcr
patient
posit
rsv
posit
hmpv
posit
frequenc
infect
increas
sequenc
analysi
part
coronaviru
genom
show
consider
similar
prototyp
sequenc
studi
demonstr
hmpv
occur
southwest
sweden
essenti
frequenc
season
distribut
clinic
characterist
report
countri
respiratori
syncyti
viru
rsv
common
viral
caus
lower
respiratori
tract
infect
young
children
follow
parainfluenza
viru
influenza
viru
virus
aetiolog
caus
identifi
mani
case
infect
number
unidentifi
caus
decreas
follow
discoveri
human
metapneumoviru
hmpv
may
reduc
still
follow
discoveri
human
coronaviru
infect
hmpv
report
mani
countri
suggest
worldwid
distribut
hmpv
seem
caus
rang
symptom
respiratori
tract
diseas
similar
caus
rsv
mainli
infant
elderli
individu
epidemiolog
hmpv
infect
appear
season
peak
late
winter
earli
spring
case
number
worldwid
report
describ
associ
upper
lower
respiratori
tract
infect
specif
clinic
croup
present
studi
present
data
obtain
nasopharyng
aspir
collect
novemb
may
children
symptom
upper
lower
respiratori
tract
infect
halmstad
sweden
sampl
analys
presenc
rsv
hmpv
simplifi
diagnost
procedur
bronchiol
sampl
rsv
hmpv
realtim
rtpcr
perform
simultan
platform
clinic
specimen
patient
data
novemb
may
nasopharyng
aspir
submit
rsv
test
examin
consecut
rna
separ
sampl
see
store
immedi
specimen
origin
outpati
clinic
inpati
ward
paediatr
depart
halmstad
hospit
remaind
gener
practition
counti
halland
sweden
specimen
obtain
patient
age
year
symptom
respiratori
tract
infect
clinic
demograph
patient
data
obtain
medic
record
patient
record
standard
form
fig
show
age
distribut
patient
sampl
taken
patient
age
year
rna
extract
c
nasopharyng
aspir
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
rna
extract
storag
complet
day
sampl
arriv
laboratori
date
sampl
collect
arriv
laboratori
ident
sampl
remain
store
overnight
deliv
follow
day
detect
rna
two
separ
nest
pcr
perform
follow
one
combin
rt
step
pcr
amplifi
sequenc
replicas
n
gene
revers
transcript
perform
use
rna
prepar
rtpcr
mix
contain
mmlvrevers
transcriptas
invitrogen
carlsbad
ca
usa
u
lm
dntp
mm
trishcl
ph
tritonx
v
v
mm
mgcl
mm
kcl
two
rt
primer
repszrt
tabl
see
supplementari
materi
pg
reaction
mix
incub
min
firstround
pcr
cdna
ad
final
reaction
volum
contain
amplitaqgold
u
lm
dntp
mm
trishcl
ph
bovin
serum
albumin
ng
mm
mgcl
mm
kcl
primer
tabl
ng
nest
pcr
perform
product
firstround
pcr
final
concentr
reaction
volum
amplitaqgold
u
lm
dntp
mm
trishcl
ph
bovin
serum
albumin
ng
mm
mgcl
mm
kcl
primer
ng
tabl
thermocycl
condit
replicas
gene
pcr
n
gene
pcr
ident
firstand
secondround
pcr
differ
number
cycl
compris
min
follow
cycl
firstround
pcr
cycl
secondround
pcr
min
min
min
final
min
pcr
product
separ
electrophoresi
agaros
gel
visualis
stain
ethidium
bromid
posit
neg
control
use
rtpcr
pcr
posit
control
consist
rna
isol
passag
cell
use
amount
rna
equival
rna
copi
rtpcr
subsequ
pcr
neg
control
steril
water
segment
n
gene
amplifi
use
onestep
realtim
rtpcr
primer
describ
fouchier
et
al
briefli
final
volum
contain
rna
prepar
nm
primer
nm
probe
taqman
univers
pcr
master
mix
multiscrib
rnase
inhibitor
taqman
onestep
rtpcr
master
mix
reagent
roch
branchburg
nj
usa
cycl
paramet
compris
min
min
cycl
min
revers
transcript
rna
amplif
detect
cdna
perform
use
abi
prism
taqman
instrument
appli
biosystem
foster
citi
ca
usa
posit
control
materi
use
convent
pcr
concentr
rna
copi
pcr
part
spike
insert
gene
sequenc
pcr
product
gene
gener
primer
list
tabl
pcr
product
realtim
rtpcr
assay
use
templat
sequenc
pcr
product
sequenc
directli
use
bigdy
termin
cycl
sequenc
kit
appli
biosystem
abi
genet
analys
appli
biosystem
biomed
laboratori
furulund
sweden
sens
antisens
strand
pcr
product
sequenc
segment
f
gene
amplifi
onestep
realtim
rtpcr
base
method
describ
maertzdorf
et
al
detect
known
hmpv
genotyp
brief
final
volum
contain
rna
prepar
nm
primer
tabl
nm
probe
taqman
univers
pcr
master
mix
multiscrib
rnase
inhibitor
assay
perform
combin
rsv
assay
cycl
paramet
instrument
describ
posit
control
consist
rna
transcrib
vitro
nucleotid
sequenc
deriv
hmpv
isol
lineag
kindli
provid
l
p
nielsen
univers
hospit
odens
denmark
pcr
product
gener
two
diagnost
primer
clone
pgem
vector
promega
madison
wi
usa
control
promot
runoff
transcript
gener
use
riboprob
invitro
transcript
system
promega
quantifi
measur
absorpt
spectrophotomet
rna
transcript
dilut
use
posit
control
copi
rtpcr
correspond
concentr
tenfold
higher
detect
limit
concentr
also
use
control
inhibitor
specimen
test
neg
pcr
multiplex
assay
rsv
rsv
b
use
primer
probe
respect
n
gene
highli
conserv
separ
rtpcr
pcr
step
describ
van
elden
et
al
combin
onestep
reaction
brief
final
volum
contain
rna
prepar
nm
primer
tabl
nm
probe
taqman
univers
pcr
master
mix
multiscrib
rnase
inhibitor
assay
perform
combin
hmpv
assay
cycl
paramet
instrument
use
ident
describ
runoff
transcript
rsv
rsv
b
use
posit
control
nucleotid
sequenc
origin
routin
sampl
ident
sequenc
primer
probe
bind
site
determin
sequenc
pcr
product
use
clone
clone
invitro
transcript
procedur
describ
hmpv
rna
transcript
dilut
use
concentr
tenfold
higher
detect
limit
evid
rsv
hmpv
nasopharyng
aspir
rsv
detect
frequent
patient
yield
posit
result
hmpv
detect
patient
three
show
posit
result
rsv
hmpv
rna
detect
patient
includ
one
coinfect
hmpv
inhibit
observ
one
sampl
rna
prepar
sampl
dilut
tenfold
retest
pcr
follow
dilut
inhibit
observ
sampl
continu
yield
neg
result
two
full
genom
sequenc
genbank
show
substanti
differ
region
spike
gene
possibl
gener
sequenc
pcr
product
gene
ten
posit
sampl
genbank
access
number
spike
gene
sequenc
show
substitut
compar
prototyp
sequenc
repres
sequenc
first
strain
detect
substitut
compar
prototyp
genet
lineag
fig
pcr
product
remain
two
sampl
test
posit
realtim
assay
also
sequenc
shown
sequenc
falseposit
reaction
replicas
gene
pcr
sampl
run
gel
second
round
pcr
two
sampl
two
differ
individu
gener
amplicon
replicas
gene
pcr
size
posit
control
amplicon
amplicon
gener
n
gene
pcr
two
sampl
gel
electrophoresi
firstround
replicas
gene
pcr
show
product
size
posit
control
secondround
pcr
bp
product
still
detect
secondround
replicas
gene
pcr
sequenc
two
product
reveal
compris
part
human
xchromosom
align
two
firstround
primer
sequenc
reveal
two
probabl
target
site
good
ident
primer
ident
primer
predict
size
result
amplif
product
bp
close
size
secondround
product
assay
bp
two
convent
rtpcr
unabl
detect
rna
copi
pcr
realtim
assay
yield
posit
result
rna
copi
pcr
differ
sensit
consist
find
four
sampl
posit
realtim
assay
sequenc
match
yield
posit
result
two
convent
pcr
two
falseposit
result
convent
replicas
gene
pcr
also
result
decreas
specif
compar
two
method
posit
sampl
individu
detect
realtim
rtpcr
assay
hmpv
eight
collect
januari
may
remain
januari
april
februari
peak
month
period
fig
three
hmpvposit
sampl
also
contain
rsv
rna
one
sampl
also
contain
rna
medic
file
patient
avail
patient
divid
four
group
rsvposit
rsv
group
hmpvposit
hmpv
group
group
neg
three
virus
neg
group
clinic
data
patient
group
summaris
tabl
three
patient
posit
rsv
hmpv
togeth
one
patient
posit
hmpv
includ
analysi
clinic
featur
patient
posit
shown
tabl
consist
find
studi
moe
et
al
arden
et
al
agreement
report
season
distribut
infect
infect
occur
rsv
hmpv
infect
fig
howev
possibl
compar
season
differ
studi
limit
data
avail
differ
climat
variou
studi
site
isol
belong
genet
lineag
may
reflect
homogen
circul
virus
within
one
season
studi
shown
cocircul
genet
divers
variant
viru
within
singl
season
littl
known
concern
genet
heterogen
viru
possibl
rtpcr
protocol
use
optim
variant
frequenc
variabl
may
greater
observ
howev
sinc
three
pcr
protocol
target
two
presum
wellconserv
gene
use
falseneg
sampl
rare
mean
age
month
patient
group
low
compar
previou
studi
overal
age
patient
group
low
fig
might
reflect
method
select
patient
paediatr
depart
children
age
year
symptom
respiratori
tract
infect
usual
phylogenet
analysi
isol
describ
studi
phylogenet
analysi
perform
use
neighbourjoin
method
mega
program
nucleotid
distanc
matrix
gener
kimura
twoparamet
estim
bootstrap
resampl
replic
use
provid
approxim
ci
individu
branch
bootstrap
valu
indic
sequenc
sever
strain
submit
previous
genbank
previou
studi
includ
analysi
treat
hospit
older
children
treat
home
gener
practition
previou
studi
contain
larger
proport
older
children
account
substanti
proport
infect
present
studi
contain
sampl
children
age
year
patient
posit
alon
comparison
previou
studi
valid
clinic
symptom
associ
infect
yet
establish
studi
found
infect
predominantli
sever
lower
respiratori
tract
infect
mainli
patient
underli
diseas
studi
report
mild
respiratori
tract
infect
previous
healthi
patient
clinic
featur
group
present
studi
tabl
tabl
indic
lower
diseas
sever
rsv
hmpv
infect
howev
nasopharyng
aspir
children
age
year
studi
caus
role
differ
clinic
manifest
age
group
yet
establish
therefor
import
conduct
wide
rang
retrospect
prospect
studi
order
obtain
better
estim
incid
clinic
effect
differ
popul
two
falseposit
pcr
result
observ
replicas
gene
pcr
product
sequenc
show
degre
homolog
part
human
xchromosom
pcr
signal
gener
quit
weak
observ
sampl
consid
sampl
contain
xchromosom
dna
fact
two
sampl
test
posit
could
reflect
sequenc
differ
primer
bind
site
xchromosom
simpli
differ
amount
xchromosom
dna
sampl
replicas
gene
pcr
could
use
screen
tool
posit
find
confirm
sequenc
higher
sensit
realtim
rtpcr
comparison
two
convent
rtpcr
togeth
conveni
protocol
support
use
method
screen
tool
addit
first
report
hmpv
infect
sweden
find
sampl
contain
hmpv
rna
compar
result
previou
studi
detect
hmpv
respiratori
sampl
nonselect
group
children
two
report
finland
posit
rate
one
denmark
posit
rate
two
norway
show
viru
circul
scandinavia
present
studi
indic
hmpv
infect
season
distribut
rsv
infect
fig
aforement
studi
document
hmpv
winter
spring
month
investig
observ
differ
age
distribut
rsvinfect
hmpvinfect
children
present
studi
observ
similar
median
age
group
hmpvinfect
children
group
rsvinfect
children
report
also
van
den
hoogen
et
al
pathogen
hmpv
compar
rsv
also
matter
debat
william
et
al
observ
differ
chest
xray
hospitalis
rate
studi
found
lower
hospitalis
rate
shorter
durat
symptom
lower
ill
score
hmpvposit
patient
present
studi
also
found
evid
shorter
hospitalis
period
hmpv
infect
similar
rate
chest
xray
taken
low
frequenc
antibiot
treatment
strengthen
observ
made
william
et
al
determin
incid
clinic
featur
hmpv
infect
test
limit
two
virus
rsv
thu
overal
burden
infect
caus
respiratori
tract
pathogen
investig
possibl
coinfect
virus
bacteria
detect
avail
simpl
quick
method
suggest
combin
test
rsv
hmpv
consid
routin
diagnost
use
virus
present
patient
group
differenti
clinic
cohort
strategi
virus
prevent
nosocomi
spread
base
techniqu
combin
realtim
assay
complement
realtim
assay
addit
diagnost
clinic
knowledg
role
differ
clinic
manifest
gain
would
like
thank
l
p
nielsen
univers
hospit
odens
denmark
provid
hmpv
rna
differ
clinic
isol
leinberg
help
review
medic
record
follow
supplementari
materi
avail
onlin
http
wwwblackwellsynergycom
tabl
sequenc
primer
probe
use
studi
